MCCARTHY SEAN A. (President and CEO) received a stock award from CYTOMX THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/6/2025ACC: 0001610717-25-000016
DirectorOfficer· President and CEO
Since Jul 2018
+1.56M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
1.56M acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+180K
Price / share
—
Trade value
—
% of position
27.4%
2/4/2025
657.85K→837.85K
Common Stock
Direct
Shares
+195K
Price / share
—
Trade value
—
% of position
23.3%
2/4/2025
837.85K→1.03M
Total
Net shares
+375K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2025 | A · Award | +180K | — | — | 27.4% | 657.85K | 837.85K |
| Common Stock Direct | 2/4/2025 | A · Award | +195K | — | — | 23.3% | 837.85K | 1.03M |
| Total | +375K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
800K shares
Shares
+800K
Strike price
0.864
Held after
800K
Exercisable
—
2/4/2025
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
390K shares
Shares
+390K
Strike price
0.864
Held after
390K
Exercisable
—
2/4/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock800K shares | 2/4/2025 | A · Award | +800K | 0.864 | — | 800K |
| Stock Option (Right to Buy) Direct | Common Stock390K shares | 2/4/2025 | A · Award | +390K | 0.864 | — | 390K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned93.16K
Total
93.16K indirect93.16K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 93.16K | Indirect |
| Total | 93.16K | 93.16K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported